| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. | Chief Financial Officer, Director | Common Stock | 10.4K | $13.8K | $1.33 | Jul 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings, Inc. | Jul 11, 2025 | 1 | $0 | 4 | Jul 15, 2025 | Chief Financial Officer, Director |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | Dec 11, 2023 | 1 | $0 | 4 | Dec 5, 2024 | Director |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | Dec 9, 2022 | 2 | -$518 | 4 | Feb 17, 2023 | Director |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | Dec 15, 2021 | 2 | -$1.66K | 4 | Apr 8, 2022 | Director |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | May 25, 2021 | 1 | -$6.39K | 4 | May 28, 2021 | Director |